Nano-X Imaging (NNOX) Competitors

Nano-X Imaging logo
$0.32 0.00 (-0.56%)
Closing price 11/16/2026 04:00 PM Eastern
Extended Trading
$0.32 -0.01 (-1.65%)
As of 11/16/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NNOX vs. OM, NRXS, HYPR, MBOT, and ECOR

Should you buy Nano-X Imaging stock or one of its competitors? Nano-X Imaging's main competitors and comparable companies include Outset Medical (OM), NeurAxis (NRXS), Hyperfine (HYPR), Microbot Medical (MBOT), and electroCore (ECOR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Nano-X Imaging compare to Outset Medical?

Outset Medical (NASDAQ:OM) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership.

Outset Medical has a beta of 1.93, meaning that its share price is 93% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.38, meaning that its share price is 38% more volatile than the broader market.

Nano-X Imaging has lower revenue, but higher earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Outset Medical$119.48M0.54-$81.65M-$3.87N/A
Nano-X Imaging$13.02M1.94-$75.02M-$2.14N/A

Outset Medical has a net margin of -58.33% compared to Nano-X Imaging's net margin of -926.05%. Outset Medical's return on equity of -66.98% beat Nano-X Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Outset Medical-58.33% -66.98% -28.40%
Nano-X Imaging -926.05%-116.93%-100.67%

21.5% of Nano-X Imaging shares are owned by institutional investors. 2.5% of Outset Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Outset Medical currently has a consensus price target of $10.00, suggesting a potential upside of 194.99%. Nano-X Imaging has a consensus price target of $4.33, suggesting a potential upside of 1,252.90%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Nano-X Imaging is more favorable than Outset Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Outset Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Nano-X Imaging
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.50

In the previous week, Nano-X Imaging had 5 more articles in the media than Outset Medical. MarketBeat recorded 8 mentions for Nano-X Imaging and 3 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.94 beat Nano-X Imaging's score of 0.33 indicating that Outset Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Outset Medical
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nano-X Imaging
1 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Nano-X Imaging beats Outset Medical on 9 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to NeurAxis?

NeurAxis (NASDAQ:NRXS) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership.

NeurAxis has a net margin of -492.76% compared to Nano-X Imaging's net margin of -926.05%. NeurAxis' return on equity of 0.00% beat Nano-X Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
NeurAxis-492.76% N/A -641.25%
Nano-X Imaging -926.05%-116.93%-100.67%

NeurAxis has a beta of 1.39, suggesting that its share price is 39% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.38, suggesting that its share price is 38% more volatile than the broader market.

NeurAxis presently has a consensus price target of $13.00, suggesting a potential upside of 170.83%. Nano-X Imaging has a consensus price target of $4.33, suggesting a potential upside of 1,252.90%. Given Nano-X Imaging's higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than NeurAxis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeurAxis
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.50
Nano-X Imaging
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.50

NeurAxis has higher earnings, but lower revenue than Nano-X Imaging. NeurAxis is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeurAxis$6.53M7.83-$14.63M-$1.06N/A
Nano-X Imaging$13.02M1.94-$75.02M-$2.14N/A

In the previous week, Nano-X Imaging had 6 more articles in the media than NeurAxis. MarketBeat recorded 8 mentions for Nano-X Imaging and 2 mentions for NeurAxis. Nano-X Imaging's average media sentiment score of 0.33 beat NeurAxis' score of 0.31 indicating that Nano-X Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NeurAxis
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Nano-X Imaging
1 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

11.8% of NeurAxis shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 21.1% of NeurAxis shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Nano-X Imaging beats NeurAxis on 9 of the 16 factors compared between the two stocks.

How does Nano-X Imaging compare to Hyperfine?

Hyperfine (NASDAQ:HYPR) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings.

Hyperfine has higher earnings, but lower revenue than Nano-X Imaging. Hyperfine is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hyperfine$11.40M5.68-$35.57M-$0.30N/A
Nano-X Imaging$13.02M1.94-$75.02M-$2.14N/A

Hyperfine has a net margin of -156.42% compared to Nano-X Imaging's net margin of -926.05%. Hyperfine's return on equity of -91.18% beat Nano-X Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Hyperfine-156.42% -91.18% -55.49%
Nano-X Imaging -926.05%-116.93%-100.67%

Hyperfine presently has a consensus target price of $2.03, indicating a potential upside of 231.91%. Nano-X Imaging has a consensus target price of $4.33, indicating a potential upside of 1,252.90%. Given Nano-X Imaging's higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than Hyperfine.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hyperfine
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.67
Nano-X Imaging
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.50

Hyperfine has a beta of 1.49, meaning that its share price is 49% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.38, meaning that its share price is 38% more volatile than the broader market.

15.0% of Hyperfine shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 26.3% of Hyperfine shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Nano-X Imaging had 2 more articles in the media than Hyperfine. MarketBeat recorded 8 mentions for Nano-X Imaging and 6 mentions for Hyperfine. Nano-X Imaging's average media sentiment score of 0.33 beat Hyperfine's score of 0.18 indicating that Nano-X Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hyperfine
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Nano-X Imaging
1 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Hyperfine beats Nano-X Imaging on 10 of the 16 factors compared between the two stocks.

How does Nano-X Imaging compare to Microbot Medical?

Nano-X Imaging (NASDAQ:NNOX) and Microbot Medical (NASDAQ:MBOT) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment.

Nano-X Imaging presently has a consensus price target of $4.33, indicating a potential upside of 1,252.90%. Microbot Medical has a consensus price target of $5.08, indicating a potential upside of 688.85%. Given Nano-X Imaging's higher possible upside, equities analysts plainly believe Nano-X Imaging is more favorable than Microbot Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nano-X Imaging
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.50
Microbot Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57

Microbot Medical has a net margin of 0.00% compared to Nano-X Imaging's net margin of -926.05%. Microbot Medical's return on equity of -21.87% beat Nano-X Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
Nano-X Imaging-926.05% -116.93% -100.67%
Microbot Medical N/A -21.87%-20.76%

Microbot Medical has lower revenue, but higher earnings than Nano-X Imaging. Microbot Medical is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nano-X Imaging$13.02M1.94-$75.02M-$2.14N/A
Microbot MedicalN/AN/A-$13.14M-$0.26N/A

Nano-X Imaging has a beta of 1.38, suggesting that its share price is 38% more volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.07, suggesting that its share price is 7% more volatile than the broader market.

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 16.3% of Microbot Medical shares are owned by institutional investors. 3.9% of Microbot Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Nano-X Imaging had 1 more articles in the media than Microbot Medical. MarketBeat recorded 8 mentions for Nano-X Imaging and 7 mentions for Microbot Medical. Nano-X Imaging's average media sentiment score of 0.33 beat Microbot Medical's score of 0.30 indicating that Nano-X Imaging is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nano-X Imaging
1 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Microbot Medical
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Nano-X Imaging and Microbot Medical tied by winning 8 of the 16 factors compared between the two stocks.

How does Nano-X Imaging compare to electroCore?

electroCore (NASDAQ:ECOR) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, profitability, dividends, media sentiment, risk and earnings.

electroCore has higher revenue and earnings than Nano-X Imaging. electroCore is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
electroCore$32.03M1.39-$13.97M-$1.39N/A
Nano-X Imaging$13.02M1.94-$75.02M-$2.14N/A

electroCore has a beta of 1.23, meaning that its stock price is 23% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.38, meaning that its stock price is 38% more volatile than the broader market.

26.7% of electroCore shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 7.8% of electroCore shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Nano-X Imaging had 1 more articles in the media than electroCore. MarketBeat recorded 8 mentions for Nano-X Imaging and 7 mentions for electroCore. electroCore's average media sentiment score of 0.91 beat Nano-X Imaging's score of 0.33 indicating that electroCore is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
electroCore
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Nano-X Imaging
1 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

electroCore has a net margin of -33.46% compared to Nano-X Imaging's net margin of -926.05%. electroCore's return on equity of 0.00% beat Nano-X Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
electroCore-33.46% N/A -74.21%
Nano-X Imaging -926.05%-116.93%-100.67%

electroCore currently has a consensus target price of $18.00, suggesting a potential upside of 271.90%. Nano-X Imaging has a consensus target price of $4.33, suggesting a potential upside of 1,252.90%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts clearly believe Nano-X Imaging is more favorable than electroCore.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
electroCore
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Nano-X Imaging
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.50

Summary

electroCore beats Nano-X Imaging on 9 of the 17 factors compared between the two stocks.

Get Nano-X Imaging News Delivered to You Automatically

Sign up to receive the latest news and ratings for NNOX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NNOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NNOX vs. The Competition

MetricNano-X ImagingHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$25.07M$5.96B$7.83B$12.17B
Dividend YieldN/A1.69%2.46%4.42%
P/E Ratio-0.1536.3133.7827.89
Price / Sales1.945.448.585.72
Price / CashN/A23.9521.9322.50
Price / Book0.164.374.403.70
Net Income-$75.02M$143.12M$3.52B$392.17M
7 Day Performance-14.20%-3.80%-4.48%-3.37%
1 Month Performance-29.28%-2.84%-3.53%-5.82%
1 Year Performance-88.68%0.21%0.12%-6.24%

Nano-X Imaging Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NNOX
Nano-X Imaging
3.9437 of 5 stars
$0.32
-0.6%
$4.33
+1,252.9%
-89.2%$25.07M$13.02MN/A197
OM
Outset Medical
3.2991 of 5 stars
$4.12
-2.6%
$10.00
+142.7%
-27.6%$83.46M$119.48MN/A310
NRXS
NeurAxis
2.7056 of 5 stars
$6.61
+5.9%
$13.00
+96.7%
+105.1%$83.01M$5.32MN/A24
HYPR
Hyperfine
2.0603 of 5 stars
$0.71
-1.3%
$2.03
+185.2%
-46.9%$79.57M$11.40MN/A102
MBOT
Microbot Medical
2.7169 of 5 stars
$1.10
-0.9%
$5.08
+362.1%
-68.9%$76.57MN/AN/A22

Related Companies and Tools


This page (NASDAQ:NNOX) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners